Cultured neurons obtained from a hypomorphous MAP1B mutant mouse line display a selective and significant inhibition of axon formation that reflects a delay in axon outgrowth and a reduced rate of elongation. This phenomenon is paralleled by decreased microtubule formation and dynamics, which is dramatic at the distal axonal segment, as well as in growth cones, where the more recently assembled microtubule polymer normally predominates. These neurons also have aberrant growth cone formation and increased actin-based protrusive activity. Taken together, this study provides direct evidence showing that by promoting microtubule dynamics and regulating cytoskeletal organization MAP1B has a crucial role in axon formation.
INTRODUCTION
Neurons are highly polarized cells that contain a single long axon and multiple dendrites. Polarization occurs when one of the multiple neurites emerging from the cell body initiates a phase of rapid elongation, becoming the axon; the remaining neurites will develop as dendrites Dotti, 1997, 1999; Dotti et al., 1998) . Because microtubule assembly and stabilization play an essential role in axon formation (Mitchison and Kirschner, 1989 ) a great deal of attention has been devoted to identify factors controlling microtubule organization and dynamics in nerve cells. Current evidence favors the view that several of the distinctive properties of neuronal microtubules, such as increased stability and spatial differentiation, arise from the developmentally regulated expression of structural microtubule-associated proteins (MAPs), which are notably abundant in neurons (Maccioni and Cambiazo, 1995) . Therefore, it is likely that the expression of these proteins along neuronal development may affect neuronal polarization.
MAP1B (Bloom et al., 1995) is the first MAP that is specifically expressed during neural development and that is especially prominent in neurons that are actively extending axons (Calvert and Anderton, 1985; Garner et al., 1990; Fischer and Romano-Clarke, 1991; Ulloa et al., 1993; Black et al., 1994 : DiTella et al., 1996 Gordon-Weeks and Fischer, 2000) . These findings led to the hypothesis that MAP1B might be involved in axon formation by regulating microtubule dynamics. Evidence in favor of this proposal came from antisense experiments showing that MAP1B suppression reduces laminin-promoted axonal elongation (DiTella et al., 1996) and neurite outgrowth in PC12 cells (Brugg et al., 1993) . More recently, it was shown that in Drosophila, an MAP1B-like protein is required for proper axonal and dendritic development Roos et al., 2000) , and that microscale chromophore-assisted laser inactivation of phosphorylated MAP1B altered growth cone turning behavior in cultured neurons (Mack et al., 2000) . The generation of MAP1B mutant mice has also provided additional important information. Despite discrepancies concerning the severity of the effects, all studies demonstrate that MAP1B-deficient mice have an impairment of brain development (Edelman et al., 1996; Takei et al., 1997; GonzalezBillault et al., 2000; Meixner et al., 2000) . Recently, mice with disrupted tau and MAP1B genes have been generated; the phenotype of these animals is markedly more severe than the one of single-tau or MAP1B mutant mice, suggesting some cooperative functions of these MAPs during brain development. (Takei et al., 2000) Unfortunately, none of these studies examined the consequences of MAP1B gene suppression on cytoskeletal organization, and therefore the functional involvement of MAP1B as a key regulator of microtubule dynamics during neuronal polarization has remained largely unexplored. In the present study, we have addressed this issue by examining the morphology, cytoskeletal organization, and dynamics of microtubule assembly in cultured hippocampal pyramidal neurons from a hypomorphous MAP1B mutant mouse line (Gonzalez-Billault et al., 2000) obtained by a gene-trapping approach (Chowdhury et al., 1997) .
MATERIALS AND METHODS

Generation and Genotyping of MAP1B Mutant Mice
The generation of heterozygous mice lacking a copy of MAP1B by a gene trap approach has been described elsewhere (Chowdhury et al., 1997; Gonzalez-Billault et al., 2000) . The gene-trapping vector (IRES␤geo) contained the EN-2 splice acceptor sequence, and IRES sequence, the neo gene, the lacZ gene, and the simian virus 40 polyadenylation signal. To genotype MAP1B mutant mice, genomic DNA from mouse tails were isolated and analyzed by polymerase chain reaction with oligonucleotides corresponding to the neo sequence (Chowdhury et al., 1997) .
Protein Extracts and Western Blots
Protein extracts were prepared from the embryonic spinal cord in 20 mM HEPES pH 7.4 containing 0.1 M NaCl, 10 mM NaF, 1 mM Na 3 VO 4 , 5 mM EDTA, 1 M okadaic acid, and protease inhibitors (2 mM phenylmethylsulfonyl fluoride and 10 g/ml aprotinin, leupeptin, and pepstatin). Protein samples were separated in SDS-PAGE, electroblotted onto nitrocellulose sheets, developed with an ECL chemiluminescence system, and quantified in a Molecular Dynamics densitometer.
Cell Culture
For the preparation of cultures, E18-19 embryos were removed aseptically from pregnant mice and placed in sterile Petri dishes. Homozygous MAP1B-deficient embryos were distinguished from controls by their abnormal limb posture (Gonzalez-Billault et al., 2000) . Dissociated cultures of hippocampal pyramidal cells from embryonic mice brain tissue were then prepared as described previously (Cáceres et al., 1986; Paglini et al., 1998) . Cultures were performed with the hippocampi of E18-19 embryos because at this time point hippocampal pyramidal neurons that develop in situ are beginning to extend neurites. To bind laminin to the substrate, polylysine-coated coverslips were soaked in Neurobasal medium containing mouse EHS laminin at a concentration of 20 g/ml overnight at 4°C as described (DiTella et al., 1996) . For some experiments nocodazole (5 g/ml) was added to the culture medium, and cells were incubated in the presence of the microtubule-depolymerizing agent for different time periods.
Primary Antibodies
The following primary antibodies were used in this study: a monoclonal (mAb) against tyrosinated ␣-tubulin (clone TUB-1A2; Sigma, St. Louis, MO) diluted 1/200; a mAb against MAP1B (clone 125; Gonzalez-Billault et al., 2000) diluted 1/150; a rabbit polyclonal antibody against MAP2 diluted 1/2000 (Sanchez-Martin et al., 1998) ; a mAb against tau (clone tau-1; Cáceres et al., 1992) diluted 1/100; a rabbit polyclonal antibody against detyrosinated ␣-tubulin diluted 1/250 (Cáceres et al., 1992) ; and the rabbit polyclonal antibody 196 against ␤II-tubulin diluted 1/100 (Armas-Portela et al., 1999) .
Immunofluorescence
Cells were prepared for immunofluorescence with the use of two procedures: 1) Fixation for 20 min with warmed 4% paraformaldehyde-0.12 M sucrose in phosphate buffer, pH 7.2; and 2) extraction with detergent to prepare "cytoskeletons fractions" according to the procedure of Brown et al. (1992) . For this procedure, the cells were washed for 30 s with buffer PHEM (60 mM piperazine-N,NЈ-bis(2-ethanesulfonic) acid, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl 2 , pH 6.9) followed by extraction (2 min) with 0.2% saponin in buffer PHEM containing 10 M taxol. Biochemical (Cáceres et al., 1992; DiTella et al., 1996) and immunofluorescence (Brown et al., 1992) studies have established that this procedure selectively removes soluble tubulin, and that the cytoskeletal fraction contains polymerized tubulin. Quantitative Western blotting has also revealed that this fraction reproducibly represents between 20 and 25% of the total cellular protein of unextracted cells, which is almost the same value obtained by other studies with the use of slightly different extraction procedures (Drubin et al., 1985; . After extraction the cells were fixed for 20 min with warmed 2% paraformaldehyde-0.05% glutaraldehyde in buffer PHEM, pH 6.9. Cultures were processed for immunofluorescence as described. For some experiments rhodamine-phalloidin (Molecular Probes, Eugene, OR) was included with the secondary antibody to visualize F-actin. The cells were analyzed with a confocal scanning microscope or with an inverted microscope (Carl Zeiss Axiovert 35 M) equipped with epifluorescence. The relative intensities of tubulin, MAP1B, MAP2, and tau immunofluorescence were evaluated in fixed unextracted cells or in detergent-extracted cytoskeletons with the use of quantitative fluorescence techniques. To image labeled cells, the incoming epifluorescence illumination was attenuated with glass neutral density filters. Images were formed on the faceplate of a Silicon Intensified Target camera, set for manual sensitivity, gain and black level (Paglini et al., 1998a,b) . Images were digitized directly into a Metamorph/Metafluor image processor controlled by a host PC computer (Universal Imaging, West Chester, PA). Fluorescence intensity measurements were perfumed within the cell body and neurites of identified neurons; with the use of these data, we then calculated the average fluorescence intensity within the cell body, and inner, middle, and distal third of identified neurites. Background levels were those detected in unlabeled cells. Photographs were printed with the use of Adobe Photoshop.
Morphometric Analysis
To measure neurite length and growth cone shape parameters (growth cone area, number, and length of filopodia) antibody-or phalloidin-labeled cells were randomly selected and traced from a video screen with the use of the morphometric menu of the Metamorph (Paglini et al., 1998a,b) . The following neuritic shape parameters were evaluated: total axonal length, length of minor processes, and total neuritic length (the sum of axonal length plus one of the minor processes). A total of 300 cells belonging to three different low-density cultures were analyzed for each experimental condition and time point. Differences among groups were analyzed by the use of analysis of variance and Student-Newman-Keuls test.
RESULTS
Delayed Axonal Formation and Growth Cone Abnormalities in Cultured Neurons from MAP1B Mutant Mice
MAP1B mutant mice were generated with the use of a gene trapping vector (IRES␤geo) transfected into R1 ES cells (Chowdhury et al., 1997;  Figure 1A ). The insertion of the vector into the MAP1B locus results in premature termination of MAP1B translation and the expression of a fusion protein with ␤-galactosidase and neomycin resistance activities, under the control of the MAP1B promoter (Chowdhury et al., 1997) . Mice carrying this mutation express trace amounts of MAP1B, display severe cortical lamination defects, and die shortly after birth (Gonzalez-Billault et al., 2000) . In this study the genotype of the embryos used for the cell culture experiments was confirmed through Western blot analysis of spinal cord extracts reacted with monoclonal antibodies against MAP1B (clone 125; Gonzalez-Billault et al., 2000) and ␤-galactosidase ( Figure 1B ).
Cultured hippocampal pyramidal neurons have been extensively used to study axon formation, as well as the expression of MAPs during neuronal morphogenesis (Craig and Banker, 1994) . Many of these studies have used laminin as an adhesive substrate, a molecule capable of enhancing polarization by promoting axonal elongation (Lein et al., 1992; Lochter and Schachner, 1993; DiTella et al., 1996) . Therefore, to assess the consequences of the disruption of the MAP1B gene on neuronal polarization, we first examined hippocampal pyramidal neurons cultured on laminin for 2 d. At this time point, virtually all neurons from wildtype (WT) animals have become polarized, displaying a long and thin axon and several (3-5) much shorter processes or minor neurites ( Figure 2A ). Axon-like neurites were also detected in neurons (55%) from MAP1B-deficient mice; however, these processes were several times shorter than equivalent ones from WT animals ( Figure 2B ). The remaining neurons lack axons, but display minor processes that appear to have an equivalent length to those of control cells. To test whether this phenomenon reflected a retraction of previously formed axons or an impairment in axon development, the neurite outgrowth response of cultured neurons from WT and mutant animals was quantitated at different time points after plating. For this analysis, an axon-like neurite was defined as a process at least twice as long as any other neurite of the same cell, and with a minimum length of 50 m (Dotti et al., 1998; Cáceres and Kosik, 1990) . The results obtained clearly revealed that neurons from MAP1B mutant mice have a selective and significant inhibition of axon formation, a phenomenon that is likely to reflect a delay in axon outgrowth and also a reduced rate of elongation (Figure 2, .
To further characterize the morphology of MAP1B-deficient neurons high-resolution confocal microscopy was used. This analysis revealed two additional important alterations: 1) An increase in actin-based protrusive activity resulting in the appearance of numerous short filopodial extensions and growth cone-like structures around the cell body and along neurites ( Figure 3 , A-C); and 2) A significant change in the shape of axonal growth cones, characterized by a retraction of the growth cone lamellipodial veil and a decrease in the number of radial striations (a chevron arrangement of actin ribs) that extends from the central growth cone region toward the periphery (Figure 3 , D-G, and Table 1 ).
Microtubule Assembly and Dynamics Are Altered in Axons of MAP1B-deficient Neurons
To determine whether MAP1B affects microtubule assembly and/or stability in developing neurons, we first addressed whether axons formed without MAP1B differ from control ones in their content of microtubule polymer. For this experiment, cultures were fixed after detergent extraction performed under microtubule-stabilizing conditions and processed for immunofluorescence with antibodies against tubulin. This method removes unassembled tubulin from the cell, so that the tubulin staining remaining in such cells is attributable to microtubules (Brown et al., 1992 ; see MATERIALS AND METHODS). ␤-Tubulin fluorescence intensity in "cytoskeletal preparations" was used as a relative measure of polymer mass because previous studies have demonstrated that it is present at a constant stoichiometry in microtubules (Brown et al., 1992) ; besides, the specific antibody to ␤-tubulin (Gonzalez-Billault et al., 2000) that we used stains all microtubules uniformly within the cell body, axons, and minor processes. Quantitative measurements revealed that the intensity of microtubule staining within axons, but not minor neurites, was significantly lower in MAP1B-deficient neurons than in WT ones (Figure 4, A and B) . Because no decrease in ␤-tubulin immunofluorescence was detected when measurements were performed in cells fixed before detergent extraction ( Figure 4C ), our observations suggest that MAP1B depletion is altering microtubule formation, by decreasing assembly and/or stability.
To distinguish between these possibilities we examined the relative amounts of two posttranslationally modified tubulins in axonal microtubules of control and MAP1B-deficient neurons. Several studies have shown that the rel- ative abundance of tyrosinated (tyr) and detyrosinated (detyr) ␣-tubulin in microtubules correlates with its stability properties such that tyr-tubulin is especially enriched in the more dynamic microtubule polymer, whereas detyr-tubulin is enriched in the more stable one (Brown et al., 1992; Li and Black, 1996) . Thus, the distribution and relative levels of these two posttranslational modifications of ␣-tubulin can be used as an indirect, but reliable, assay of microtubule dynamics. This correlation is particularly strong in growing axons, in which the more dynamic polymer is highly concentrated at neuritic tips, whereas the more long-lived polymer is prominent in the proximal axon (Figure 5, A-C) . This pattern is clearly altered in axons from MAP1B-deficient neurons; thus, a dramatic decrease in tyrmicrotubule staining paralleled by an increase in detyrmicrotubule labeling is evident at the distal axonal segment ( Figure 5, D-F) . Quantitative measurements confirmed these observations, and clearly revealed that the balance between dynamic and stable microtubule polymer is significantly altered in axons from MAP1B-deficient neurons (Figure 5, G and H) .
To complement these experiments we examined whether MAP1B mutation alters microtubule sensitivity to depolymerizing agents. For such a purpose, the effect of treatment with nocodazole on the loss of tubulin polymer from the distal part of the axon contiguous to the growth cone was measured. The polymer in this region is labile to treatment with nocodazole declining in amount with a half-life of ϳ5-10 min. For this experiment nocodazole was added to the medium to 5 g/ml and incubated for up to 60 min. The results obtained show that nocodazole produces a significant decrease in the tyr-microtubule staining of both WT and MAP1B-deficient neurons. Comparisons of tyr-fluorescence intensity within axonal tips of untreated and nocodazoletreated WT neurons revealed that after a 5-min nocodazole pulse, the tyr-tubulin polymer decreases more than 75%; in contrast, a much smaller decrease (30%) was detected in equivalent regions of MAP1B-deficient neurons ( Figure 6 , A and B). This result suggests that the population of newly stabilized microtubules is relatively larger in MAP1B-deficient neurons than in WT ones, a finding that is consistent with the increase in detyr-microtubule labeling detected in the mutant neurons. As another test of the consequences of MAP1B suppression on microtubule dynamics, we examined microtubule regrowth during recovery from treatment with nocodazole (30 min). To examine regrowth the cultures were rinsed with fresh medium to remove nocodazole, and incubated for a further 5-to 60-min period. In controls neurons, recovery was evident as the appearance of segments of tyr-tubulin staining in the cell body and at neuritic tips, as soon as 5 min after the release from nocodazole. In contrast, MAP1B-deficient neurons have an extremely slow microtubule recovery; thus, even 60 min after nocodazole release, only a slight increase in tyr-microtubule staining was detected in axonal tips of neurons from the MAP1B mutant mice ( Figure 6C ).
Functional Redundancy in Neurons from MAP1B-deficient Mice
It has been suggested that a functional redundancy might exist among MAPs (Harada et al., 1994; DiTella et al., 1996; Takei et al., 2000) . Therefore, we looked for the existence of such a compensatory mechanism with the use of quantitative fluorescence to measure changes in the relative levels of MAP2 and tau, proteins that have been directly implicated in the regulation of microtubule dynamics and process outgrowth in developing neurons Kosik, 1990, 1992; Harada et al., 1994) . No significant changes in the fluorescence intensity or distribution of MAP2 or tau immunostaining were detected between WT and MAP1B-deficient neurons when cells were fixed before detergent extraction ( Figure 7, A and B) . In contrast, in "cytoskeletal preparations" a significant increase in MAP2 immunostaining was detected in axons of MAP1B-deficient neurons. However, because these axons are significantly shorter than the ones of WT neurons, the possibility exists that this phenomenon Within neurites measurements were performed in the initial segment (IS), inner segment (Int), middle segment (Med), external segment (Ext), and growth cones (GC) of axons and minor processes. Note that ␤-tubulin fluorescence intensity is dramatically reduced in the external axonal segment and in axonal growth cones (C). Equivalent measurements to those shown in A, but from cells extracted with detergents after fixation. Note that there are no significant differences in fluorescence intensity between WT and MAP1B-deficient neurons. A total of 75 cells was analyzed for each experimental condition. Each value represents the mean Ϯ SEM.
reflects a lower degree of maturation (Cáceres et al., 1986) rather than a compensatory mechanism. To distinguish between these possibilities, a comparison of MAP2 immunofluorescence was performed in WT and MAP1B-deficient neurons having axons of equivalent length. Even under this condition we detected significantly more MAP2 immunostaining in axons of mutant neurons than in WT ones (Figure 7, C-F) . Tau immunofluorescence associated with the axonal cytoskeleton was almost identical in WT and MAP1B-deficient neurons. Because axons of mutant neurons contain less tubulin polymer than WT ones, these results suggest that tau also increases its association with axonal microtubules in the absence of MAP1B. 
DISCUSSION
The present results, based on the analysis of cultured neurons obtained from a hypomorphous mouse line having a decrease of Ͼ95% in MAP1B protein levels (Gonzalez-Billault et al., 2000) , provide the first direct experimental evidence suggesting that MAP1B has a crucial participation in axon formation by promoting microtubule assembly and dynamics. Thus, cultured hippocampal pyramidal neurons from MAP1B-deficient mice display a selective delay in axonal outgrowth and also a reduced rate of elongation. This phenotype is paralleled by a significant decrease in the content of axonal microtubules, and particularly of the more dynamic polymer containing tyr-tubulin. Although this phenomenon was observed throughout the entire extent of axons, it was dramatic in the distal axonal segment, as well as in growth cones, where the more recently assembled polymer predominates (Brown et al., 1992; Baas et al., 1993; Li and Black, 1996) . Additional evidence, supporting a role for MAP1B in the promotion of microtubule assembly, came from the analysis of microtubule regrowth during recovery from treatment with nocodazole. Whereas in WT neurons recovery was evident as the appearance of segments of tyr-tubulin staining in the cell body and at axonal tips as soon as 5 min after the release from nocodazole, in MAP1B-deficient neurons this phenomenon was severely impaired.
Regarding these observations, it is worth noting that the association of MAP1B with axonal microtubules precisely mimics the distribution of newly assembled polymer. In developing neurons MAP1B preferentially binds to microtubules located in the distal axon and the growth cone region (Black et al., 1994; DiTella et al., 1996) . An increase in MAP-1B phosphorylation occurs during brain development; more importantly, phosphorylation of MAP1B in "prolinedirected" serine-threonine residues precisely parallels axon formation in cultured neurons and promotes MAP1B binding to microtubules at the distal axonal end (DiTella et al., 1996) . Interestingly, two proline-directed protein kinases, namely, cyclin-dependent kinase 5 (Cdk5) and glycogen synthase kinase 3 ␤ (GSK3␤), which are highly enriched at the distal tip of growing axons and phosphorylate MAP1B, are also required for axonal elongation (Nikolic et al., 1996; Pigino et al., 1997; Paglini et al., 1998a; Lucas et al., 1998) .
A question that now arises concerns the relationship between MAP1B-promoted microtubule assembly and stability. The significance of stable microtubules that serve as templates for nucleating tubulin assembly along axonal shafts and at axonal tips is now well established Li and Black, 1996) . These stable microtubules, which are poor in tyr-tubulin, resistant to nocodazole, and with a half-life of several hours, provide a structural basis for the active tubulin assembly that occurs in growing axons. According to this model, a decrease in stable microtubules would decrease assembly. Because nonneuronal cells over- expressing MAPs, including MAP1B heavy and/or light chains, display enhanced microtubule bundling and stability (Takemura et al., 1992; Vandecandelaere et al., 1996; Togel et al., 1998) , the possibility exists of MAP1B having a similar role in developing neurons. However, the present results do not favor the view of MAP1B acting as a microtubule-stabilizing factor; they rather suggest that MAP1B acts as a factor limiting microtubule stabilization. Supporting this, we showed that axons from MAP1B-deficient neurons have a significant increase in the relative amount of detyr-microtubules and also a higher proportion of recently stabilized polymer. Interestingly, inhibition of GSK3␤ activity with lithium, which reduces MAP1B phosphorylation and binding to growth cone microtubules (Lucas et al., 1998; Goold et al., 1999) , results in a dramatic increase in the number of stable detyr-microtubules in the distal axonal segment of cultured neurons (Goold et al., 1999) . Conversely, COS cells transfected with both MAP1B and GSK3␤ express high levels of phosphorylated MAP1B associated with tyr-microtubules, and a decrease in detyr-tubulin polymer (Goold et al., 1999) . Taken together, these observations suggest that, in addition to promoting microtubule assembly, another major function of MAP1B in developing neurons involves maintaining a dynamic microtubule polymer in regions of active growth.
One possible mechanism underlying such a function may involve MAP1B competing with other MAPs for microtubule binding sites. For example, the association of MAP1B with microtubules may result in decreased binding of other MAPs, which otherwise might contribute to microtubule stabilization. Supporting such a proposal, we showed that MAP2 and tau, which are potent microtubule-stabilizing factors Takemura et al., 1992; LeClerk et al., 1993) significantly increase their association with axonal microtubules in MAP1B-deficient neurons.
Regardless of the precise mechanism, MAP1B participation in the maintenance of a dynamic microtubule polymer may be important for allowing interactions between microtubules and actin filaments during growth cone advance and axon extension. Thus, recent studies have shown that dynamic microtubules positively regulate actin dynamics during cell motility . For example, the stabilization of microtubule assembly/disassembly without substantial microtubule polymer loss or disorganization stops cell migration (Liao et al., 1995; Tanaka and Kirschner, 1995; Mikhailov and Gundersen, 1998) . Besides, in migrating cells lamellipodial protrusion is highly correlated with the presence of dynamic microtubules near the base of lamellipodia; in contrast, a smaller lamellipodial area and slower movement are associated with microtubules spending more time in pause (Mikhailov and Gundersen, 1998) . Moreover, the growth of microtubules in fibroblasts leads to activation of small GTPases such as rac1, which in turn results in actin polymerization and protrusion of the leading lamellipodia . Similar mechanisms appear to operate in neurons because growing microtubules also activate site-directed F-actin assembly in nerve growth cones (Rochlin et al., 1999) . Interestingly, immunoelectron microscopy has revealed that microtubules penetrating into the growth cone peripheral domain contain MAP1B and interact with actin filament bundles (Bush et al., 1996; Gordon-Weeks and Fischer, 2000) . Therefore, by favoring the existence of dynamic microtubules within growth cones, MAP1B may contribute to the promotion of lamellipodial spreading, an event required for neuronal polarization Dotti, 1997, 1999; Paglini et al., 1998b) . In favor of this idea, we observed a significant reduction in the size of the lamellipodial veil and a decrease in the number of actin ribs in axonal growth cones of MAP1B-deficient neurons.
Our results also raise the possibility of MAP1B having a more direct involvement in the regulation of actin organization. Previous studies have shown that MAP1B, and in particular the MAP1B light chain, can bind to actin filaments in vitro (Pedrotti and Islam, 1996) , and to stress fibers in vivo (Togel et al., 1998) . In addition, it was found that the COOH terminus of the light chain can efficiently target the NH 2 terminus of MAP1B heavy chain to stress fibers (Togel et al., 1998) . In this study, we have extended these observations by showing that in MAP1B mutant neurons actin-based protrusive activity is up-regulated and mislocalized. Thus, one striking morphological alteration in MAP1B-deficient neurons is the appearance of numerous short filopodial extensions and growth cone-like structures around the cell body and along neurites. This phenomenon, which is not restricted to axons, may reflect the lack of dephosphorylated MAP1B in the subcortical cytoskeleton of cell bodies, neurites, and growth cones of developing neurons, where it is normally found (DiTella et al., 1996; Paglini et al., 1998a) . In future studies, it will be of considerable interest to explore the mechanisms underlying the alterations in actin organization observed in MAP1B-deficient neurons.
Finally, the present results suggest that during the initial stages of axon formation neither MAP2 nor tau are capable of compensating MAP1B deficiency. Although redundant functions of MAP1B and tau have been reported for cultured cerebellar macroneurons treated with antisense oligonucleotides during the initial establishment of neuronal polarity (DiTella et al., 1996; Paglini et al., 2000) , no such an effect was observed in MAP1B mutant hippocampal pyramidal neurons. Recently, a double MAP1B and tau mutant mouse has been generated (Takei et al., 2000) . Based on the analysis of the phenotype of these animals, the authors claimed the existence of some synergic effects of the two proteins. It is worth noting that the double mutant animals were obtained by breeding a tau mutant line that overexpresses MAP1A in response to the tau deficiency (Harada et al., 1994) with a MAP1B hypomorphic mutant line (Takei et al., 1997) . Therefore, this phenotype may not have an easy interpretation and this must be carefully taken into account.
However, the fact that after several days in culture most MAP1B-deficient neurons extend axons, albeit much shorter than those of WT cells, suggests the existence of some kind of mechanism that partially compensates the lack of MAP1B. Whether this involves MAP2, tau, or other MAPs remains to be established.
ACKNOWLEDGMENTS
This work was supported by grants from the Spanish Dirección General de Investigació n Cientifica y Ténica, Comunidad de Madrid, European Union, and an institutional grant from Formation de Recherche Associee to J.A. It was also supported by grants from Consejo Nacional de Investigaciones Cientificas y Técnicas de Argentina (PICT-PIP 4906), FONCyT (PICT 05-00000-00937 and 99-5-6179), CONICOR, and a Howard Hughes Medical Institute Grant (HMMI 75197-553201) awarded under the International Research Scholars Program to A.C. An A.E.C.I./I.C.I. predoctoral fellowship was awarded to C.G.-B. The MAP1B mutant mouse was generated with financial support from Amgen and the Max Planck Society in the laboratory of Prof. P. Gruss.
